Complete consensus nucleotide sequences were determined for human metapneumovirus (HMPV) isolates CAN97-83 and CAN98-75, representing the two proposed genotypes or genetic subgroups of HMPV. The overall level of genome nucleotide sequence identity and aggregate proteome amino acid sequence identity between the two HMPV subgroups were 80 and 90%, respectively, similar to the respective values of 81 and 88% between the two antigenic subgroups of human respiratory syncytial virus (HRSV). The diversity between HMPV subgroups was greatest for the SH and G proteins (59 and 37% identity, respectively), which were even more divergent than their HRSV counterparts (72 and 55% cross-subgroup identity, respectively). It is reasonable to anticipate that the two genetic subgroups of HMPV represent antigenic subgroups approximately comparable to those of HRSV.
Introduction
Human metapneumovirus (HMPV) was first recovered in 2001 in the Netherlands from infants and children experiencing acute respiratory tract disease (van den Hoogen et al., 2001) . HMPV has been classified presumptively in the Metapneumovirus genus, Pneumovirus subfamily, Paramyxovirus family of the Order Mononegavirales, the nonsegmented negative-strand RNA viruses or mononegaviruses. HMPV has since been isolated in several continents, suggesting that it is worldwide in prevalence, and resembles human respiratory syncytial virus (HRSV) with regard to disease signs and the ability to infect and cause disease in the young infant as well as individuals of all ages Peret et al., 2002; Falsey et al., 2003; Osterhaus and Fouchier, 2003) . HRSV is the type species of the Pneumovirus genus, the other genus of the Pneumovirus subfamily (Collins et al., 2001 ). The prevalence, overall impact on human health, age association, antigenic diversity, and other aspects of HMPV epidemiology and biology remain to be characterized more completely.
HMPV is an enveloped virus with a genome that is a single negative strand of RNA of approximately 13 kb. A nucleotide sequence was determined for most of the genome of the prototype isolate 00 -1 (Genbank Accession No. AF371337) (van den Hoogen et al., 2002) , although the ends of the genome were not mapped or sequenced. This analysis showed that, similar to the avian metapneumoviruses (AMPV), the 3Ј to 5Ј HMPV gene order is N-P-M-F-M2-SH-G-L. The mRNA encoded by the M2 gene contains two overlapping open reading frames (ORFs) M2-1 and M2-2 that have the potential to encode separate proteins, as has been confirmed for HRSV (Collins et al., 1990 (Collins et al., , 1996 Bermingham and Collins, 1999; Jin et al., 2000) . By analogy to AMPV and HRSV, the HMPV proteins are as follows: N, nucleocapsid RNA binding protein; P, nucleocapsid phosphoprotein; M, nonglycosylated matrix protein; F, fusion glycoprotein; M2-1, transcription elongation factor; M2-2, RNA synthesis regulatory factor; SH, small hydrophobic surface protein; G, major attachment protein; L, major polymerase subunit. These predicted HMPV proteins have not yet been identified or characterized biochemically and their functions have not yet been confirmed.
Comparison of sequences available for several HMPV genes or gene fragments showed that the available HMPV isolates can be grouped into two broad genotypes or subgroups (van den Hoogen et al., 2001; Peret et al., 2002; Bastien et al., 2003) , perhaps analogous to the two antigenic subgroups A and B of HRSV (Anderson et al., 1985; Mufson et al., 1985; Johnson et al., 1987a,b; Collins, 1988a,b, 1989) . In the present study we (i) determined the first complete sequence for an HMPV genome and (ii) compared complete genome sequences for isolates representing the two proposed genetic subgroups of HMPV. This analysis supports the idea that these two genetic clusters are subgroups that are approximately comparable in cross-subgroup sequence divergence to the antigenic subgroups of HRSV.
Results and discussion

Comparison of complete consensus genome sequences
HMPV isolates CAN97-83 and CAN98-75 Peret et al., 2002) were propagated in vitro in LLC-MK2 cells and virion RNA was isolated and subjected to reverse transcription (RT)-PCR. The cDNA products were analyzed by nucleotide sequencing performed directly on the uncloned material to determine consensus sequences. Primers designed from the published sequence for isolate 00-1 usually did not successfully prime on either CAN isolate, presumably due to sequence divergence. We therefore designed primers to take advantage of putative conserved gene-start and gene-end signals flanking the viral genes. This provided initial sequence data from which additional primers specific to either CAN isolate were designed. The CAN97-83 isolate provided an unambiguous sequence for its entirety, whereas the CAN98-75 isolate yielded a sequence in which a number of positions in the SH and G genes contained a mixture of two assignments. This suggested that the isolate was a mixture of two or more viruses that likely reflected quasispecies variants, either present in the original clinical sample or arising during in vitro passage. Analysis of cloned RT-PCR products spanning the SH and G genes produced two closely related sets of sequences that likely represented at least two different viruses. To obtain a sequence that could unambiguously be attributed to a single replication-competent CAN98-75 virus, the isolate was subjected to biological cloning by plaque isolation. Eight independent plaque-purified preparations yielded identical consensus sequences in the region of SH and G that were consistent with that of one of the two groups of cloned cDNA sequences. This sequence appears to represent the major constituent and was taken to be CAN98-75.
The 3Ј and 5Ј ends of the CAN97-83 and CAN98-75 genomes were mapped and sequenced by RT-PCR-based rapid amplification procedures (see Materials and methods) and the uncloned products were analyzed by nucleotide sequencing, yielding unambiguous sequences. In addition, the CAN97-83 genome was circularized with RNA ligase and the region containing the joined ends was amplified by RT-PCR. The resulting product was sequenced directly and also was cloned, and 20 individual clones were sequenced. These results were in complete agreement with those of the rapid amplification protocols. The sequences of the 3Ј leader region and the downstream end of the 5Ј trailer region of the two CAN isolates are shown in Fig. 1A , revealing a very high degree of relatedness between the two and a somewhat lower degree of relatedness with AMPV and HRSV.
The genomes of isolates CAN97-83 and CAN98-75 were 13,335 and 13,280 nucleotides in length, respectively (GenBank Accession No. AY297749 and AY297748, respectively). Their gene maps are shown in Fig. 1B . Overall, the two genomes shared 80% nucleotide identity, compared to 81% between the A2 and B1 strains of HRSV representing the two HRSV antigenic subgroups A and B, respectively (GenBank Accession No. M74568 and AF013254, respectively). Similarly, the nucleotide sequence of CAN98-75 was 80% identical to that of isolate 00-1 (excluding the regions for which sequence was unavailable for 00-1), representing a second cross-subgroup comparison. The sequences of CAN97-83 and 00-1, representing an intra-subgroup comparison, were 92% identical.
For most genera of the Paramyxovirus family, there is a "rule of six," whereby the nucleotide length of each genome is an even multiple of six (Kolakofsky et al., 1998) . In many cases, the placement of cis-acting signals relative to hexamer spacing also follows a conserved pattern. However, HMPV replication and gene expression do not appear to be ruled by a phasing requirement based on the following observations: (i) the sequences for the three available isolates differ in length (CAN97-83, 13,335 nucleotides; CAN98-75, 13,280 nucleotides; and 00-1, 13,378 nucleotides, which was calculated assuming that the 00-1 termini correspond in length to the others); (ii) no integer from 2 to 9 was evenly divisible into each of the three genomes; and (iii) there was no apparent pattern of phasing for the gene boundaries within or between isolates.
The genome of a mononegavirus, and presumably that of HMPV, is transcribed beginning at its 3Ј end by a linear, sequential, stop-restart process. Transcription is guided by short gene-start and gene-end signals that flank each gene and direct transcription initiation and termination/polyadenylation, respectively (Lamb and Kolakofsky, 2001 ). Fig. 2 shows putative gene-start, gene-end, and intergenic sequences of HMPV. The downstream end of each HMPV gene is delineated by the putative 12-to 15-nucleotide gene-end motif (consensus: AGTTAnnnAAAAA). This motif is the same as that of HRSV (consensus: AGTTAnnnAAAAA) (Collins et al., 2001 ), consisting of (in positive sense) a highly conserved AGTTA pentamer, followed by a poorly conserved A/T-rich trinucleotide, followed by a tract of four to seven A residues. A sequence that resembles the gene-end motif also is present near the downstream end of the HMPV leader region (Fig. 2 ), but further work will be needed to determine whether this functions similar to a gene-end signal.
The upstream end of each HMPV gene is delineated by the 16-nucleotide gene-start motif (consensus: GGGACAAnTnnnAATG; Fig. 2 ). The first 10 nucleotides of this motif have some resemblance to the 10-nucleotide genestart signal of HRSV (consensus: GGGGCAAAT[A/T]) (Collins et al., 2001) . One unusual feature of the gene-start signal of all HMPV isolates sequenced to date is the presence of ATG at positions 14 -16 ( Fig. 2) , which initiates the major ORF. In the SH gene of CAN98-75 and 00-1, there is an additional upstream ATG at gene-start positions 8 -10; however, this start site is unlikely to be used because of its unfavorable sequence context. Further work will be needed to determine whether the ATG at positions 14 -16 is a functional element of the HMPV gene-start signal or whether the conserved spacing of this translational start site plays some other role in gene expression.
The organization of the HMPV genome is compact. Except for the internal M2-2 ORF, each ORF initiated at nt 14 of its mRNA, and in four (CAN97-83) or five (CAN98-75) of the eight mRNAs, the ORF terminated within the gene-end signal. Thus, noncoding gene regions are short. Taking strain CAN98-75 as an example, 93.8% of the genome was involved in ORFs, and 96.7% of the genome was represented in the predicted array of monocistronic mRNAs. Table 1 shows the nucleotide sequence relatedness of the various HMPV ORFs between the two putative genetic subgroups (CAN97-83 versus CAN98-75) and within a subgroup (CAN97-83 versus 00-1). Between the subgroups, the HMPV ORFS shared 81-87% nucleotide identity except for (Randhawa et al., 1997) and HRSV strain A2. Shading denotes identity among at least three sequences. (B) Gene maps of HMPV isolates CAN97-83 and CAN98-75. Individual genes are indicated by boxes, with gene lengths and boundaries within the complete genomic sequence given in nucleotides together with the unmodified amino acid length (italics) of the deduced protein (in the case of M2, two predicted proteins, M2-1 and M2-2). The nucleotides lengths of the extragenic 3Ј leader, 5Ј trailer, and intergenic regions are underlined.
Sequence relatedness of ORFs and proteins between subgroups
SH and G, which were substantially more divergent (69 and 59% identity, respectively). This pattern resembled that of the two subgroups of HRSV, for which the percentage of nucleotide identity for the various ORFs was 81-85% identical except for the more divergent M2-2, SH, and G ORFs (69, 77, and 67% identity, respectively; Table 1 ). For comparison, the HMPV intergenic regions and the noncoding gene regions (exclusive of gene-start and gene-end signals) were 48 and 54% identical, respectively, between subgroups, compared to values of 42 and approximately 50%, respectively, for HRSV (Johnson and Collins, 1988b) . Thus, the coding sequence for HMPV G was only marginally more conserved than were HMPV noncoding gene sequences in general (59 versus 54%). Extensive nucleotide sequence divergence for SH and, in particular, G also was observed between two (67) 92 (85) a Amino acid sequence identities were calculated based on the complete predicted proteins; in the case of G and SH, overhangs on the carboxy-terminal side of alignments due to length differences were not included in the calculations. Nucleotide sequence identities for the corresponding ORFs are shown in parentheses and are based on the protein-coding sequence exclusive of flanking noncoding sequence. For comparison, the HMPV intergenic regions were 48% identical between subgroups and noncoding gene sequences exclusive of conserved transcription signals were 54% identical, compared to values of 42% and approximately 50% for HRSV (Johnson and Collins, 1988b) . strains of the same subgroup (CAN97-83 versus 00-1, Table 1 ). Table 1 also shows the amino acid sequence relatedness of the various HMPV proteins between the two subgroups (CAN97-83 versus CAN98-75), and within a subgroup (CAN97-83 versus 00-1). With regard to the total proteome, the HMPV subgroups shared 90% amino acid sequence identity, compared to 88% identity between the HRSV subgroups. With regard to individual proteins, the most conserved HMPV proteins were N, M, F, M2-1, and L (ϭ94% identity between subgroups), followed by P and M2-2 (85-89%), followed by the divergent SH (59%) and G (37%) proteins. SH and G are the only ones for which the percentage of relatedness at the amino acid level was less than at the nucleotide level, suggesting that amino acid substitutions were preferentially retained. While this article was in preparation, Bastien et al. (2003) reported sequences for the N, P, M, and F genes of 15 HMPV isolates: their results for these four genes and proteins are similar to those shown in Table 1 .
The pattern of HMPV sequence diversity between subgroups has general similarities to that of HRSV (Table 1) . For HRSV, the "internal" virion proteins and the F protein constituted a group of highly conserved species, while the M2-2, SH, and G proteins were more divergent. The three following differences between HMPV and HRSV will be described in greater detail below: (i) the HMPV M2-2 protein was markedly more conserved (89% amino acid identity between subgroups) than its HRSV counterpart (61%); (ii) the HMPV F protein also was more conserved than was the case for HRSV (95% identity between subgroups versus 89%); and (iii) the HMPV SH and G proteins were markedly more divergent than their HRSV counterparts (59 and 37% identity between subgroups, respectively, compared to 72 and 55%, respectively). Table 1 also compares the HMPV proteins within a subgroup (CAN97-83 versus 00-1). For most of the proteins, the percentage of amino acid identity was very high (ϭ95%), with the SH and G proteins being more divergent (85 and 70% identity, respectively). The value of 70% sequence identity for G within an HMPV subgroup is much lower that the value of 91% reported for HRSV G from the analysis of seven subgroup B strains (Sullender et al., 1991) . Thus, the HMPV SH protein and, in particular, the G protein were markedly more divergent within and between subgroups than was the case for their HRSV counterparts.
It was surprising to find that the HMPV M2-2 ORF and protein exhibited a high level of identity between the two putative subgroups, since M2-2 of HRSV is poorly conserved (Table 1 ). In the case of HRSV, the M2-2 protein was identified as a functional gene product by the observation that disruption of its ORF in infectious recombinant virus resulted in altered virus growth and RNA synthesis (Bermingham and Collins, 1999; Jin et al., 2000) . The HRSV M2-2 ORF is expressed by a ribosomal stop-restart mechanism, whereby ribosomes that exit the M2-1 ORF apparently double back and initiate translation at the overlapping M2-2 ORF (Ahmadian et al., 2000) . For the HMPV M2-2 ORF, there are two possible methionyl translational start sites located 38 and 50 nucleotides upstream of the translational termination codon of the M2-1 ORF. These two sites are exactly conserved among all three strains compared here and are embedded in highly conserved sequence.
As noted by van den Hoogen et al. (2002) , the HMPV F, SH, and G proteins appear to correspond to the three HRSV surface glycoproteins F, SH, and G, although there was clear sequence relatedness between HMPV and HRSV counterparts only for F (33% amino acid identity). For HRSV, G, and F are the only significant neutralization antigens and are the major protective antigens (Collins et al., 2001) , whereas experiments in rodents suggested that the HRSV SH protein is not a significant protective antigen (Connors et al., 1991) . The neutralization and protective antigens of HMPV remain to be described. The HRSV F protein has a high degree of antigenic relatedness between subgroups (Johnson et al., 1987a) , consistent with its sequence relatedness (Table 1) , and is the major contributor to HRSV cross-subgroup neutralization and protection. For HMPV F, amino acid sequence identity between subgroups was even higher than for HRSV, and it is reasonable to anticipate that this similarly will make a substantial contribution to cross-neutralization and cross-protection between the HMPV subgroups. Conversely, the high degree of divergence of the G protein between and within HMPV subgroups likely will compromise its contribution to crossneutralization and cross-protection to an even greater degree than is the case for HRSV (Johnson et al., 1987a) . Detailed descriptions of the sequence of the HMPV F protein have recently been published (van den Hoogen et al., 2002; Bastien et al., 2003) .
The HMPV SH protein, similar to its HRSV counterpart, is predicted to be a type II glycoprotein that is inserted in the plasma membrane by a hydrophobic signal/anchor sequence located near its amino-terminus (Fig. 3A, boxed sequence) , with a cytoplasmic amino-terminus and an extracellular carboxy-terminus. The SH proteins of isolates CAN98-75, CAN97-83, and 00-1 varied in length (177, 179, and 183 amino acids, respectively; Fig. 3A ) and were considerably longer than their 64-or 65-amino-acid counterparts in HRSV. The predicted extracellular domain has two to four motifs for N-linked glycosylation, one of which is conserved in all three isolates, as well as three or four potential sites for O-glycosylation (Hansen et al., 1998) that are clustered within residues 75-81 in all three isolates (Fig.  3A) . In addition, the SH proteins of the three isolates contain 9 or 10 cysteine residues, which are mostly in the extracellular domain, 9 of which are conserved among all three strains. The differences in length and amino acid sequence between the SH proteins of the different isolates were concentrated in the extracellular domain.
The HMPV G protein (Fig. 3B ) also is a type II surface protein, bearing a general resemblance (but no significant sequence relatedness) to the G protein of HRSV. The amino acid lengths of the G proteins of isolates CAN98-75; CAN97-83, and 00-1 were 236, 219, and 236, considerably shorter than their 289-to 299-amino-acid counterparts in HRSV. The HMPV G protein, similar to its HRSV counterpart, contains a high percentage of serine plus threonine residues (32-35% for the three isolates, compared to a data base average of 13%) and a somewhat elevated level of proline residues (7-8.5%, compared to an average of 5%). CAN97-83, CAN98-75, and 00-1 had one, four, and four, respectively, potential acceptor sites for N-linked glycosylation in the ectodomain. Each HMPV G protein contained more than 40 predicted potential (Hansen et al., 1998) acceptor sites for O-linked carbohydrate (not shown): by analogy to HRSV it is likely that not all of these are used, and usage might be heterogeneous. The serine, threonine, proline residues, and the predicted sites for O-linked sugars were concentrated in the predicted extracellular domain, suggesting that this region has a long, extended, heavily glycosylated "mucin-like" structure, as is thought to be the case for RSV. Fig. 3 . Alignment of the amino acid sequences of the (A) SH and (B) G proteins of HMPV strains CAN98-75, CAN97-83, and 00-1. This includes comparison between (CAN98-75 versus CAN97-83) and within (CAN97-83 versus 00-1) the proposed HMPV genetic subgroups. For strains CAN98-75 and 00-1, assignments that differ from that of CAN97-83 are shown; dashes indicate gaps introduced to maximize the alignment or to denote the absence of corresponding amino acids. Stars underneath each alignment denote amino acid identity among all three sequences; small dots indicate amino acid similarity among all three. Proposed signal/transmembrane domains are boxed. Motifs for N-linked carbohydrate are underlined (N-X-T/S, where X is not proline). In A, cysteine residues conserved among all three SH proteins are indicated with large dots, and potential sites for O linked glycosylation (Hansen et al., 1998) of the SH proteins are as follows: 75, 77, 78, 81; 78, 79, 81, [0] [1] 77, 78, 81. The HMPV G protein also resembles that of HRSV in having most of the amino acid divergence localized to the extracellular domain (Fig. 3B) . Specifically, the cytoplasmic and transmembrane domains combined were 64 and 96% identical between and within subgroups, respectively, compared to the remarkably low values for the extracellular domain of 25 and 61% identity between and within subgroups. For comparison, the value of 25% amino acid sequence identity is comparable to that observed for the attachment hemagglutinin-neuraminidase protein of parainfluenza viruses from different genera, such as genus Paramyxovirus versus genus Rubulavirus or Avulavirus, and is substantially lower than the value of 42-66% identity observed for the influenza A hemagglutinin glycoprotein between subtypes H1, H2, and H3.
The HMPV G protein lacks several of the prominent features of its HRSV counterpart. HMPV G lacks the conserved 13-amino-acid domain in the HRSV G extracellular domain that is exactly conserved among all HRSV strains and is partially conserved in bovine RSV (Johnson et al., 1987b; Teng and Collins, 2002) . Indeed, the HMPV G ectodomain did not contain more than three adjacent amino acids conserved among all three isolates. HMPV G also lacks the four conserved, closely spaced cysteine residues in HRSV G that partially overlap the 13-amino-acid conserved domain, form a cystine noose, and include a CX3C chemokine motif (Tripp et al., 2001 ). The three HMPV G proteins in Fig. 3B each contained only one or two cysteine residues, with the only conserved one being at the inner face of the cytoplasmic domain, representing a potential acceptor site for fatty acid acylation. HMPV G also lacks a counterpart to the second methionyl translational start codon in the HRSV G ORF, which gives rise to a secreted form and is conserved between HRSV subgroups (Roberts et al., 1994) . Only isolate CAN98-75 has an appropriately located potential counterpart (methionine-43), and it is the fourth rather than the second methionyl residue.
For HRSV G, a high percentage of the nucleotide substitutions in the extracellular domain were shown to result in amino acid coding changes, suggestive of a selective pressure for amino acid change that is thought to be due to host immunity (Johnson and Collins, 1989; Sullender et al., 1991) . Here, we extended this analysis to the extracellular domains of the HMPV F, SH, and G proteins (data are shown only for F and G in Table 2 ), based on alignments between the two putative subgroups (isolates CAN97-83 versus CAN98-75). In each coding sequence alignment, those codons having nucleotide differences were grouped according to whether one, two, or three nucleotides were involved: this was done because we particularly wanted to focus the comparison on codons having a single nucleotide difference, since this would directly demonstrate the likelihood of an amino acid change per single nucleotide change. Remarkably, 75% of the single nucleotide substitutions in the G ectodomain were found to be associated with amino acid substitutions (Table 2 ), compared to the value of 50% for SH (not shown) and the low value of 6.8% for F, the last being comparable to that observed for internal protein genes (Johnson and Collins, 1989) . This pattern also was observed for the codons with two nucleotide changes ( Table 2) . Repeating an argument that we previously made for HRSV (Johnson et al., 1987b; Johnson and Collins, 1988a) , we suggest that the extraordinary frequency of amino acid substitution per nucleotide substitution in HMPV G (and to a lesser extent SH) reflects two factors: (i) selective pressure for amino acid change, which might come from host immunity; and (ii) the ability of the protein to tolerate substitution, which might be due to its proposed extended, unfolded nature. In contrast, HMPV F appears to resemble HRSV F, which is one of the more highly conserved proteins despite its status as a major HRSV neutralization and protective antigen. This likely reflects functional and structural constraints on amino acid substitution in this folded, globular glycoprotein. The time scale of nucleotide and amino acid substitution for HMPV is not known, but we note that, for HRSV, it is difficult to detect antigenic drift and thus the differences probably reflect a slow accumulation over years.
In conclusion, complete genome sequences were determined for two HMPV isolates representing the two proposed HMPV genetic subgroups. This completed the sequencing of the HMPV genome. Comparison of the a Sequence alignments between CAN97-83 and CAN98-75 for the coding sequences for the extracellular domains of G or F (exclusive of signal, transmembrane, and cytoplasmic sequences) were inspected and codons containing nucleotide substitutions were grouped according to the number of substitutions. Each group was then sub-divided on the basis of whether the nucleotide substitution(s) resulted in an amino acid substitution.
b The value for HRSV G was 58% (Johnson and Collins, 1989) . c The value for HRSV F was 15% (Johnson and Collins, 1989) .
nucleotide and predicted amino acid sequences showed that the divergence between these two subgroups is comparable overall to that of the two HRSV antigenic subgroups. Among the three surface proteins, the HMPV F protein was highly conserved, even more so than for HRSV, while the SH and G proteins were highly divergent, even more so than for HRSV.
Material and methods
Cells and viruses
LLC-MK2 (ATCC CCL 7.1) cells were maintained in OptiMEM I (Invitrogen GIBCO) supplemented with 5% fetal bovine serum. HMPV CAN97-83 and CAN98-75 are clinical isolates Peret et al., 2002) and were propagated in our laboratory at 32°C in the presence of 5 g/ml trypsin.
RNA isolation
Virion-associated RNA was isolated directly from clarified medium supernatants using the QIAamp viral RNA purification kit (Qiagen) according to the manufacturer's instructions. Alternatively, virus was purified from the supernatants by centrifugation on a 30 to 60% w/v sucrose step gradient for 90 min at 26,000 rpm in an SW28 rotor. The virus-containing fraction was diluted in TEN [10 mM Tris-HCl (pH 7.4), 0.1 M NaCl, 1 mM EDTA] and virus particles were pelleted by centrifugation at 25,000 rpm in an SW28 rotor for 90 min. The virus pellet was resuspended in 500 l of TEN and RNA was isolated using the RNeasy kit (Qiagen) according to the manufacturer's instructions.
RT-PCR and nucleotide sequencing
Virion RNA was mixed with 50 pmol of each different primer and incubated for 5 min at 70°C and 25 min at 60°C. Reverse transcription with Superscript II enzyme (Invitrogen) was performed at 44°C for 1 h and at 51°C for 30 min. PCR was performed with Platinum Pfx DNA polymerase (Invitrogen). Nucleotide sequences of cDNA products were determined by direct sequence analysis of the RT-PCR products using an ABI 3100 sequencer with the Big-Dye terminator ready reaction kit v1.1 (Applied Biosystems).
To map and sequence the 3Ј end of the HMPV genome, virion RNA was converted into cDNA and amplified using the 3Ј RACE System for Rapid Amplification of cDNA Ends (Invitrogen) as specified by the manufacturer. Briefly, vRNA was polyadenylated at its 3Ј-end using poly(A) polymerase (Invitrogen) followed by first-strand cDNA synthesis primed with oligo(dT) and PCR using an HMPV specific reverse primer and a forward UAP primer supplied with the kit. Then, RACE products were used as template for a nested-PCR using an internal HMPV specific reverse primer and the AUAP primer supplied with the kit to improve the specificity of the reaction. Finally, the amplified cDNA nested-PCR products were sequenced directly.
To map and sequence the 5Ј end of the HMPV genome, virion RNA was processed by first-strand cDNA synthesis using a primer specific to the downstream end of the HMPV L gene, terminal transferase tailing, and PCR amplification as specified by the 5Ј RACE System for Rapid Amplification of cDNA 5Ј end Version 2.0 (Invitrogen) using the AAP primer supplied with the kit. Then, the amplified cDNA RACE products were used as template for a nested-PCR using an internal HMPV specific primer and the AUAP primer supplied with the kit to improve the specificity of the reaction. Finally, the amplified cDNA nested-PCR products were sequenced directly.
The 5Ј and 3Ј ends of the HMPV CAN97-83 genome also were confirmed by genomic RNA ligation and RT-PCR followed by sequencing. Briefly, vRNA isolated from sucrose gradient purified virus was ligated in presence of 10 U of T4 RNA ligase (Epicentre) for 3 h at 25°C and 3 h at 37°C. A cDNA corresponding to the junction of the ligated ends was synthesized and amplified by RT-PCR using HMPV specific primers from the upstream end of the N gene and downstream end of the L gene. The RT-PCR products were used as template for a nested-PCR using additional HMPV primers that hybridize closer to the respective termini to improve the specificity of the reaction. Finally, the nested-PCR products were cloned into a blunt vector (pSTBlue-1; Novagen) and 20 clones were sequenced, thereby independently confirming the length, content, and sequence of the two ends of the HMPV genome.
